Drug Discovery Informatics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):–
The Global Drug Discovery Informatics Market reached US$ 3.11 billion in 2023 and is expected to reach US$ 8.01 billion by 2031 growing with a CAGR of 12% during the forecast period 2024-2031.
List of the Key Players in the Drug Discovery Informatics Market:
Certara, Charles River Laboratories, Collaborative Drug Discovery, Inc., Eurofins DiscoverX, Jubilant Biosys Ltd., Selvita, Chemaxon Ltd., Oracle, Accenture, and IBM
Industry Development:
In May 2024, Certara, Inc. partnered with Cloudscientific to enhance access to its cutting-edge discovery informatics platform, D360, and its secure AI solution, Certara.AI, for China's growing RD sector.
In the same month, Valence leveraged Oracle Cloud Infrastructure (OCI) as an AI-driven platform to develop advanced foundation models for drug discovery, optimizing computational power to improve efficiency and innovation in pharmaceutical research.
Growth Forecast Projected:
The Global Drug Discovery Informatics Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Drug Discovery Informatics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Segment Covered in the Drug Discovery Informatics Market:
By Function: Clinical Trial Data Management, Molecular Modeling, Sequence Analysis Platforms, Docking Studies, Others
By Solution: Software, Services
By Application: Drug Discovery, Drug Development
By End-User: Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Others
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
